Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibody proteases: induction of catalytic response.
Gabibov AG, Friboulet A, Thomas D, Demin AV, Ponomarenko NA, Vorobiev II, Pillet D, Paon M, Alexandrova ES, Telegin GB, Reshetnyak AV, Grigorieva OV, Gnuchev NV, Malishkin KA, Genkin DD. Gabibov AG, et al. Among authors: genkin dd. Biochemistry (Mosc). 2002 Oct;67(10):1168-79. doi: 10.1023/a:1020971509138. Biochemistry (Mosc). 2002. PMID: 12460115 Free article.
Liposome-encapsulated peptides protect against experimental allergic encephalitis.
Belogurov AA Jr, Stepanov AV, Smirnov IV, Melamed D, Bacon A, Mamedov AE, Boitsov VM, Sashchenko LP, Ponomarenko NA, Sharanova SN, Boyko AN, Dubina MV, Friboulet A, Genkin DD, Gabibov AG. Belogurov AA Jr, et al. Among authors: genkin dd. FASEB J. 2013 Jan;27(1):222-31. doi: 10.1096/fj.12-213975. Epub 2012 Oct 9. FASEB J. 2013. PMID: 23047895 Free PMC article.
Chemical Polysialylation of Recombinant Human Proteins.
Smirnov IV, Vorobiev II, Belogurov AA, Genkin DD, Deyev SM, Gabibov AG. Smirnov IV, et al. Among authors: genkin dd. Methods Mol Biol. 2015;1321:389-404. doi: 10.1007/978-1-4939-2760-9_26. Methods Mol Biol. 2015. PMID: 26082236
CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study.
Belogurov A Jr, Zakharov K, Lomakin Y, Surkov K, Avtushenko S, Kruglyakov P, Smirnov I, Makshakov G, Lockshin C, Gregoriadis G, Genkin D, Gabibov A, Evdoshenko E. Belogurov A Jr, et al. Neurotherapeutics. 2016 Oct;13(4):895-904. doi: 10.1007/s13311-016-0448-0. Neurotherapeutics. 2016. PMID: 27324388 Free PMC article. Clinical Trial.
Chemical polysialylation of human recombinant butyrylcholinesterase delivers a long-acting bioscavenger for nerve agents in vivo.
Ilyushin DG, Smirnov IV, Belogurov AA Jr, Dyachenko IA, Zharmukhamedova TIu, Novozhilova TI, Bychikhin EA, Serebryakova MV, Kharybin ON, Murashev AN, Anikienko KA, Nikolaev EN, Ponomarenko NA, Genkin DD, Blackburn GM, Masson P, Gabibov AG. Ilyushin DG, et al. Among authors: genkin dd. Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1243-8. doi: 10.1073/pnas.1211118110. Epub 2013 Jan 7. Proc Natl Acad Sci U S A. 2013. PMID: 23297221 Free PMC article.
Chemical Polysialylation and In Vivo Tetramerization Improve Pharmacokinetic Characteristics of Recombinant Human Butyrylcholinesterase-Based Bioscavengers.
Terekhov SS, Smirnov IV, Shamborant OG, Bobik TV, Ilyushin DG, Murashev AN, Dyachenko IA, Palikov VA, Knorre VD, Belogurov AA, Ponomarenko NA, Kuzina ES, Genkin DD, Masson P, Gabibov AG. Terekhov SS, et al. Among authors: genkin dd. Acta Naturae. 2015 Oct-Dec;7(4):136-41. Acta Naturae. 2015. PMID: 26798501 Free PMC article.
Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF-α and IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients.
Lomakin Y, Belogurov A Jr, Glagoleva I, Stepanov A, Zakharov K, Okunola J, Smirnov I, Genkin D, Gabibov A. Lomakin Y, et al. Mediators Inflamm. 2016;2016:2847232. doi: 10.1155/2016/2847232. Epub 2016 Apr 28. Mediators Inflamm. 2016. PMID: 27239100 Free PMC article. Clinical Trial.
Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma.
Stepanov AV, Markov OV, Chernikov IV, Gladkikh DV, Zhang H, Jones T, Sen'kova AV, Chernolovskaya EL, Zenkova MA, Kalinin RS, Rubtsova MP, Meleshko AN, Genkin DD, Belogurov AA Jr, Xie J, Gabibov AG, Lerner RA. Stepanov AV, et al. Among authors: genkin dd. Sci Adv. 2018 Nov 14;4(11):eaau4580. doi: 10.1126/sciadv.aau4580. eCollection 2018 Nov. Sci Adv. 2018. PMID: 30443597 Free PMC article.
14 results